We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

158 hedge funds and large institutions have $1.28B invested in NEVRO CORP. in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 74 increasing their positions, 47 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 47

2% less call options, than puts

Call options by funds: $9.57M | Put options by funds: $9.73M

7% less funds holding

Funds holding: 170158 (-12)

15% less capital invested

Capital invested by funds: $1.5B → $1.28B (-$224M)

39% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 28

Holders
158
Holders Change
-12
Holders Change %
-7.06%
% of All Funds
2.52%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
74
Reduced
47
Closed
28
Calls
$9.57M
Puts
$9.73M
Net Calls
-$163K
Net Calls Change
-$2.69M
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
51
Jane Street
New York
$2.81M +$1.79M +50,908 +190%
AQR Capital Management
52
AQR Capital Management
Connecticut
$2.77M +$1.8M +51,307 +203%
Legal & General Group
53
Legal & General Group
United Kingdom
$2.7M +$253K +7,193 +11%
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
$2.7M -$920K -26,203 -26%
Swiss National Bank
55
Swiss National Bank
Switzerland
$2.62M -$299K -8,500 -10%
EGM
56
Engineers Gate Manager
New York
$2.51M +$1.97M +56,165 +423%
HF
57
HRT Financial
New York
$2.42M -$93K -2,649 -4%
ECM
58
ExodusPoint Capital Management
New York
$2.11M +$285K +8,123 +16%
Envestnet Asset Management
59
Envestnet Asset Management
Illinois
$1.97M +$67.2K +1,914 +4%
Connor, Clark & Lunn Investment Management (CC&L)
60
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.94M -$182K -5,180 -9%
Tudor Investment Corp
61
Tudor Investment Corp
Connecticut
$1.87M -$616K -17,543 -25%
N
62
Numerai
California
$1.83M +$1.78M +50,716 New
GCM
63
Graham Capital Management
Connecticut
$1.77M +$434K +12,364 +34%
RhumbLine Advisers
64
RhumbLine Advisers
Massachusetts
$1.7M +$26.1K +744 +2%
California State Teachers Retirement System (CalSTRS)
65
California State Teachers Retirement System (CalSTRS)
California
$1.54M -$22.5K -640 -1%
BA
66
Bridgewater Associates
Connecticut
$1.54M +$55K +1,566 +4%
AllianceBernstein
67
AllianceBernstein
Tennessee
$1.49M -$7.41K -211 -0.5%
Acadian Asset Management
68
Acadian Asset Management
Massachusetts
$1.4M +$748K +21,305 +122%
Russell Investments Group
69
Russell Investments Group
United Kingdom
$1.35M -$476K -13,563 -27%
UBS AM
70
UBS AM
Illinois
$1.33M
ETC
71
Exchange Traded Concepts
Oklahoma
$1.32M +$158K +4,511 +14%
AG
72
Algert Global
California
$1.26M +$25.6K +728 +2%
Manulife (Manufacturers Life Insurance)
73
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.24M +$492 +14 +0%
KI
74
Kula Investments
Illinois
$1.22M +$875K +24,921 +280%
WG
75
Winton Group
United Kingdom
$1.21M +$514K +14,637 +77%

NVRO Hedge Fund Activity: Q1 2023 in Review

158 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q1 2023, worth a combined $1.28B — down 15% from $1.5B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of NVRO and 17 opened new positions — a net loss of 11 holders — while 47 trimmed existing stakes and 74 added.

The largest buyer was Braidwell, adding an estimated $15.5M. The largest seller was BlackRock, cutting an estimated $49.7M.

  • 158 institutional investors held NEVRO CORP. (NVRO) as of Q1 2023, down from 170 in Q4 2022.
  • Funds reported $1.28B of NEVRO CORP. stock for Q1 2023, down 15% quarter-over-quarter.
  • 17 funds opened new NEVRO CORP. positions in Q1 2023 and 28 closed out, a net change of -11 holders.
  • The largest NEVRO CORP. buyer in Q1 2023 was Braidwell, an estimated $15.5M added.
  • The largest NEVRO CORP. seller in Q1 2023 was BlackRock, an estimated $49.7M sold.

Based on aggregated 13F filings for Q1 2023.